Quick Evidence Summary
| Evidence type | Current status |
|---|---|
| Controlled human trials | Exist for oral glutathione; results are mixed by dose, duration, population |
| 4-week trial, healthy adults | No significant change in blood glutathione or oxidative markers |
| 6-month trial, older adults with T2D | Measurable increases in glutathione; improved oxidative and HbA1c markers |
| IV glutathione | Used clinically off-label; not FDA-approved for any indication |
| Regulatory status | Legal OTC dietary supplement (oral); naturally occurring in the body |
What Glutathione Is
Glutathione (GSH) is a tripeptide built from three amino acids, glutamate, cysteine, and glycine, that your body synthesizes on its own in nearly every cell, with the liver as the primary production site. Unlike most compounds covered on this site, it is not a foreign substance or a novel research chemical; it's one of the most abundant molecules in human cells, and levels naturally decline with age, chronic illness, poor diet, and oxidative stress. It's sold in oral (capsule/tablet), liposomal, and IV/injectable forms, each with a different evidence and regulatory picture.
What the Controlled Trials Found
A controlled human trial of 500mg oral glutathione twice daily for four weeks in healthy adults found no significant change in blood glutathione status or oxidative stress markers versus placebo. That null result lines up with the mechanistic concern that oral glutathione is substantially broken down by digestive enzymes before meaningful absorption occurs.
A separate six-month trial in older adults with type 2 diabetes told a different story: it found measurable increases in blood glutathione and improvements in oxidative-damage and HbA1c markers. The two trials differed in both duration (four weeks versus six months) and population (healthy adults versus an older, metabolically compromised group with likely lower baseline glutathione and more oxidative stress to improve upon).
Why this matters: "does glutathione work" doesn't have one answer. The honest reading of these two trials is that oral glutathione's effect, if any, may depend heavily on baseline status, dose, and duration, rather than being a uniform result you can assume applies to any healthy adult over any timeframe.
IV Glutathione: Clinical Use Without FDA Approval
IV and injectable glutathione bypass digestion entirely and are administered directly into the bloodstream, typically in a clinical or med-spa setting, for uses like skin lightening or general "detox" framing. Despite that clinical-looking delivery, IV and injectable glutathione are not FDA-approved for any indication, including skin lightening, detoxification, or Parkinson's disease. In February 2019, the FDA warned compounding facilities against using certain L-glutathione powder in sterile injectables after adverse events linked to bacterial endotoxin contamination in the raw material, a quality-control concern specific to the injectable supply chain rather than the oral supplement market.
Regulatory Status
Glutathione is a naturally occurring molecule your body already makes, and oral glutathione is sold as a standard, legal over-the-counter dietary supplement, a meaningfully different regulatory position than compounds like IGF-1 LR3 or KPV, which are unapproved research chemicals with no legal human-use pathway. That legal OTC status for the oral form doesn't extend to the IV route, which remains unapproved for any indication despite its common clinical use.
Bloodwork to Track
There's no single glutathione-specific blood marker in routine clinical use, though some functional-medicine practitioners order red blood cell glutathione or oxidative stress panels. See the peptide bloodwork guide for what a general baseline panel typically includes.
Related Reading
For dosing by form and the full regulatory breakdown, see the glutathione reference page. BioStackIQ's Rate My Stack and Build Protocol can help you think through where a compound like this fits into a broader stack, with this evidence picture in mind.